# Alinea Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alinea-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Cambridge, US
- Total disclosed funding: $45M
- Latest round: Series A (Oct 20, 2005)
- Investors on record: 4

## About

Founded in 2005, Alinea Pharmaceuticals, Inc. develops pharmaceuticals for the treatment of diabetes and related metabolic disorders.

## Funding rounds

- Series A, Oct 20, 2005, $45M — Burrill & Company, Flagship Pioneering, SV Health Investors, MPM BioImpact

## Investors

- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series A
- Flagship Pioneering (https://capitalatlas.ai/funds/flagship-pioneering) — Series A
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series A
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series A
